Study Stopped
The research study was not funded.
Improving Relationships Using Motivational Interviewing
IRMIT
A Multilevel Approach to Improving Patient-Clinician Relationships and Outcomes in African American Patients With Diabetes Using Artificial Intelligence-Enhanced Motivational Interviewing Training
1 other identifier
interventional
N/A
1 country
2
Brief Summary
This research aims to optimize patient-clinician relationships through motivational interviewing training in a Federally Qualified Health Center (FQHC) to improve health outcomes for African American patients with Type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2022
CompletedFirst Posted
Study publicly available on registry
January 25, 2023
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedMarch 5, 2024
March 1, 2024
Same day
December 22, 2022
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in perceptions of the patient-clinician relationship by patients of participating residents.
The Patient-Doctor Relationship Questionnaire-9 (PDRQ-9) will be used to assess the patient's subjective perception of the quality of the patient-clinician relationship.The PDRQ-9 consists of 9 statements, for which there are response options ranging from 1 (not at all appropriate) to 5 (totally appropriate). Scores range from 9 to 45 with higher scores being more desirable.
Measured every 3 months up to 4 years.
Secondary Outcomes (7)
Perceptions of psychological safety by patients of participating residents.
Measured every 3 months up to 4 years.
Levels of self-reported patient activation by patients of participating residents.
Measured every 3 months up to 4 years.
HbA1c levels of patients of participating residents.
Measured every 3 months up to 4 years.
Changes in the percentage of time the resident speaks in role plays in motivational interviewing practice.
Measured every 3 months up to 3 years.
Changes in the ratio of open-ended to closed-ended questions used by the resident in role plays in motivational interviewing practice.
Measured every 3 months up to 3 years.
- +2 more secondary outcomes
Study Arms (1)
Enhanced Motivational Interviewing Training
EXPERIMENTALParticipating medical residents will all receive two successive interventions, motivational interviewing (MI) booster training and the use of a dashboard that provides MI metrics. The booster training will make use of an artificial intelligence tool developed by our study team, Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI), that produces metrics on important conversational skills (e.g., talking time, use of open-ended questions). The dashboard will produce these metrics during clinical encounters as a way to provide cuing for the MI approach.
Interventions
The training in motivational interviewing that medical residents will receive will make use of an artificial intelligence measurement tool, Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI), that produces a spectrum of relevant MI metrics.
Eligibility Criteria
You may qualify if:
- Eligible participants are residents in Family Medicine and Internal Medicine residency programs at Wright State University who will be recruited to participate in the study.
You may not qualify if:
- None
- Note: Patients of these participating residents will be invited to participate in the study by providing survey and health data at specified intervals, but these patients will not be the direct recipients of any intervention in this study. Eligible patients will be self-identifying African American individuals ages 18 and over with a diagnosis of Type 2 diabetes, and are patients of either Family Medicine or Internal Medicine residents participating in this study. The target number of patients is 200.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wright State Universitylead
- Five Rivers Health Centerscollaborator
- Kennesaw State Universitycollaborator
Study Sites (2)
Five Rivers Health Centers
Dayton, Ohio, 45417, United States
Wright State University
Dayton, Ohio, 45435, United States
Related Publications (2)
Vasoya MM, Shivakumar A, Pappu S, Murphy CP, Pei Y, Bricker DA, Wilson JF, Castle A, Hershberger PJ. ReadMI: An Innovative App to Support Training in Motivational Interviewing. J Grad Med Educ. 2019 Jun;11(3):344-346. doi: 10.4300/JGME-D-18-00839.1. No abstract available.
PMID: 31210875BACKGROUNDHershberger PJ, Pei Y, Bricker DA, Crawford TN, Shivakumar A, Vasoya M, Medaramitta R, Rechtin M, Bositty A, Wilson JF. Advancing Motivational Interviewing Training with Artificial Intelligence: ReadMI. Adv Med Educ Pract. 2021 Jun 4;12:613-618. doi: 10.2147/AMEP.S312373. eCollection 2021.
PMID: 34113205BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul J Hershberger, PhD
Wright State University Boonshoft School of Medicine
- PRINCIPAL INVESTIGATOR
Dean A Bricker, MD
Wright State University Boonshoft School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2022
First Posted
January 25, 2023
Study Start
February 1, 2024
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
March 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Deidentified group data will be made available to other researchers but no individual participant data will be shared.